MA-AI-RAN-ALLIANCE
The AI-RAN Alliance is pleased to announce the appointment of Dr. Alex Jinsung Choi, Principal Fellow of SoftBank Corp.'s Research Institute of Advanced Technology, to Chair. As the Chair of the AI-RAN Alliance, Choi is fully committed to working alongside prominent technology, industry and academic institution members to help accelerate the adoption and growth of AI-RAN (artificial intelligence-radio access networks) technology, supported by 5G and 6G technologies.
"The AI-RAN Alliance is set to transform telecommunications through AI-RAN advancements, increased efficiency, and new economic opportunities," said Choi. "As Chair, I’m excited to lead this AI-RAN initiative, working with industry leaders to enhance mobile networks, reduce power consumption, and modernize infrastructure with 5G and 6G with AI/ML. Our goal is to drive societal progress through AI-RAN, transitioning from traditional to next-generation communications infrastructure."
Choi brings over 30 years of experience in the telecom industry, having served many past corporate leadership roles in research and development of various technological domains such as mobile networks and AI/ML (AI/machine learning). He has also been a distinguished figure in industry associations, formerly as the Chairman of the O-RAN ALLIANCE where he had played an integral part in driving the successful delivery of O-RAN specifications and transforming RAN towards open and intelligent solutions.
Under Choi's leadership, the AI-RAN Alliance will leverage the collective expertise of its members to advance research and innovation in three main areas: AI-for-RAN, which focuses on enhancing radio access network capabilities with AI to improve spectral efficiency; AI-and-RAN, which integrates AI with RAN processes to optimize infrastructure use and create new revenue opportunities; and AI-on-RAN, which deploys AI services at the network edge to increase operational efficiency and provide new services to mobile users. Network operators in the alliance will spearhead the testing and implementation of these technologies, developed through the collaborative efforts of member companies and universities.
Supporting Quotes from Founding Members:
Satadal Bhattacharjee, Sr. Director of Marketing, Infrastructure BU, ARM, said, “We're excited to collaborate with Choi, the Chair of the AI-RAN Alliance. Like Choi, we believe that AI will fundamentally change the way wireless services are deployed, fostering broad innovation and enhancing operational efficiency. We look forward to working with key industry leaders from silicon to software to fulfill the promise of ubiquitous AI and 6G.”
Jim Shea, Co-founder and CEO of DeepSig, said, “As a pioneer in AI-native communications together with his prior experience growing the O-RAN ALLIANCE, Choi will lead this important initiative that is shaping the future of intelligent radio access networks. DeepSig's extensive AI/ML wireless expertise will play a key role in this exciting collaboration to leverage advanced technologies to help the industry unlock unprecedented network efficiency and accelerate innovation.”
Mathias Riback, VP & Head of Advanced Technology U.S., Ericsson, said, "I'm thrilled to welcome Dr. Choi as Chair of the AI-RAN Alliance. As a non-standardization organization, the Alliance can uniquely complement the work of existing SDOs by focusing on shaping innovative use cases that integrate AI with RAN. In addition to realizing benefits from AI in RAN implementations, it will be important to advance 'AI on RAN' use cases, where mobile networks play a critical role in enabling AI applications. Ericsson is fully committed to fostering a collaborative environment that unites all players in the evolving AI ecosystem to shape the future of telecom together."
Shawn Hakl, VP of 5G Strategy, Microsoft, said, "At Microsoft, we recognize artificial intelligence (AI) as a pivotal technology of our era. We are excited to be a part of the AI-RAN Alliance and are particularly pleased to see Choi step into the role of Chair. Choi's leadership will be key as we collaborate to leverage AI in optimizing RAN infrastructure investments and expanding the capabilities of RAN to introduce new AI-driven services for modern mobile applications.”
Ari Kynäslahti, Head of Strategy and Technology, Mobile Networks at Nokia commented, “Nokia is proud to be part of the AI-RAN Alliance and contribute towards integrating AI into radio access networks. The potential of AI to optimize networks, predict and resolve issues, and enhance performance and service quality is significant. As we embark on this transformative journey, collaboration is essential to harness our collective expertise. We are pleased to see Dr. Alex Choi appointed to this role, and look forward to him guiding our efforts to achieve these goals.”
Tommaso Melodia, William L. Smith Professor, Northeastern University, said, “We are pleased to have Choi as the Chair of the AI-RAN Alliance, leading our efforts to transform the industry. Choi has been a strong advocate for the evolution towards a more open, software-driven, and AI-integrated future. Under Choi's leadership, the AI-RAN Alliance is set to fast-track the development of new services and use cases by leveraging openness, softwarization, and AI integration to enhance network performance, energy efficiency, spectrum sharing, and security, ultimately redefining the landscape of global communications.”
Soma Velayutham, GM, AI and Telecoms, NVIDIA, said, “The AI-RAN Alliance is a critical initiative for advancing the convergence of AI and 5G/6G technologies to drive innovation in mobile networks. The consortium’s new leadership will bring a fresh perspective and focus on delivering the next generation of connectivity.”
Dr. Ardavan Tehrani, Samsung Research, AI-RAN Alliance Board of Directors Vice Chair, said, "We are excited to have Dr. Alex Choi leading the AI-RAN Alliance as the Chair of the Board. The Alliance will play a pivotal role in fostering collaboration, driving innovation, and transforming future 6G networks utilizing AI. Under Dr. Choi's leadership, the Alliance will strive to deliver substantial value to end users and operators through pioneering AI-based use cases and innovations.”
Ryuji Wakikawa, VP and Head of Research Institute of Advanced Technology, SoftBank Corp., said, "SoftBank is committed to realizing an AI-powered network infrastructure, and we strongly believe that Choi’s extensive background and expertise will be a great force in advancing AI-RAN technology and driving significant progress for the mobile industry in this AI era with lightning speed."
John Saw, EVP and CTO, T-Mobile, said, “We are thrilled to have Alex Choi as Chair of the AI-RAN Alliance. AI is advancing at an unprecedented rate and with our 5G network advantage we have a unique opportunity to harness this momentum. By developing solutions that make the most of both RAN and AI on GPUs — and working alongside Choi and the top industry leaders within the Alliance — we believe there is potential for change that will revolutionize the industry.”
Dr. Akihiro Nakao, Professor, The University of Tokyo, said, “Dr. Alex Jinsung Choi’s appointment as Chair of the AI-RAN Alliance represents a pivotal step in advancing AI within the telecommunications sector. His leadership is expected to unite academic and industry efforts, nurturing the next wave of innovators who will drive the future of AI and telecommunications. This initiative will not only fast-track the adoption of AI across diverse applications but also foster international collaboration and set new standards for efficiency, energy management, resilience, and the development of AI-driven services that will reshape the telecommunications industry and benefit society worldwide.”
About AI-RAN Alliance
The AI-RAN Alliance is a collaborative consortium focused on enabling the evolution and advancement of AI integration into RAN. Established in 2024, the alliance strives to promote innovation, establish best practices, and drive the development of AI technologies that enhance the performance, efficiency, and flexibility of RAN systems used in telecommunications. For more information, visit: https://ai-ran.org/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240815774457/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aspect Announces CEO Leadership Transition and New Independent Board7.1.2026 00:13:00 CET | Press release
Aspect, a leading provider of cloud-based workforce management solutions, has announced a leadership transition, including the appointment of Jeff Kupietzky as Interim Chief Executive Officer and the formation of a new independent Board of Directors, marking an important next chapter for the company. As part of this transition, Darryl Kelly will step down as Chief Executive Officer and transition into a Strategic Advisor role, effective January 1, 2026. Darryl led Aspect through a pivotal period of transformation, helping reposition the business, refine its vision, and reinvigorate its innovation and execution. The company and its stakeholders thank Darryl for his leadership and contributions during a period of meaningful change. With Darryl continuing as Strategic Advisor, the organization retains continuity for employees, customers, and stakeholders. “Aspect is starting a new season, building upon the strong foundation we’ve created together,” said Darryl Kelly. “This transition is a
Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 21:00:00 CET | Press release
Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar
SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 20:35:00 CET | Press release
The Society is welcoming 40 new Fellow Members from across the globe SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support
Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 20:00:00 CET | Press release
Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 19:30:00 CET | Press release
Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 statusHigh GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impactResults to be presented as a Late-Breaking Abstract Oral Presentation at ASCO GI on January 8, 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
